Home/Filings/4/0001250853-15-000104
4//SEC Filing

Galena Biopharma, Inc. 4

Accession 0001250853-15-000104

$SLSCIK 0001390478operating

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 8:27 PM ET

Size

6.1 KB

Accession

0001250853-15-000104

Insider Transaction Report

Form 4
Period: 2015-12-18
Knapp Thomas J
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2015-12-18+225,000225,000 total
    Exercise: $1.50Exp: 2025-12-18Common Stock (225,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
  • [F2]The stock option will vest in 16 equal, quarterly installments over 4 years, beginning 3 months from the date of grant, so long as the Reporting Person remains in the company's continuous employ of the Issuer through the vesting period.

Issuer

Galena Biopharma, Inc.

CIK 0001390478

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001390478

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 8:27 PM ET
Size
6.1 KB